Haemonetics | HAE - Ordinary Share Capital


Haemonetics reported $46.83M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Avanos Medical USD 46.42M 102.94K Sep/2025
Baxter International USD 514.28M 168.72M Dec/2025
Becton, Dickinson and Co. USD 284.91M 1.72M Dec/2025
Boston Scientific USD 1.48B 1.46B Jun/2025
Cooper Companies USD 198.81M 9K Sep/2025
Fresenius EUR 563.24M 0 Sep/2025
Fresenius Medical Care EUR 289.85M 3.56M Sep/2025
Globus Medical USD 135.05M 134.92M Jun/2025
Haemonetics USD 46.83M 82K Dec/2025
Hologic USD 222.57M 350K Sep/2025
ICU Medical USD 24.69M 2K Dec/2025
Intuitive Surgical USD 354.5M 3.98M Dec/2025
Masimo USD 53.1M 1.2M Sep/2025
Medtronic USD 1.28B 116K Sep/2025
Merit Medical Systems USD 59.29M 72K Sep/2025
Neogen USD 217.53M 227K Sep/2025
OraSure Technologies USD 0 0 Jun/2024
Quidel USD 67.9M 200K Sep/2025
ResMed USD 145.97M 25K Dec/2025
STAAR Surgical USD 49.28M 238K Jun/2025
Steris USD 98.15M 344K Dec/2025
Stryker USD 382.4M 93K Dec/2025
Surmodics USD 716K 4K Sep/2024
Teleflex USD 44.19M 482K Jun/2025
Terumo JPY 1.48B 0 Dec/2025
Thermo Fisher Scientific USD 375.71M 1.9M Dec/2025
US Physical Therapy USD 15.2M 15.03M Jun/2025
Zimmer Biomet Holdings USD 198.18M 18.44K Dec/2025